PURPOSE: To evaluate the usefulness of magnetic resonance imaging (MRI) in assessing the level of activity of acute Charcot foot, monitoring treatment response and predicting healing time. MATERIALS AND METHODS: Forty diabetic patients with acute Charcot foot were prospectively enrolled. Patients underwent limb immobilization and were followed every 3 months by clinical examination (skin temperature and circumferences) and MRI. MR protocol included T1-weighted and fast spin echo inversion recovery (FSE-IR) sequences, and a dynamic study (fast spoiled gradient echo), after gadolinium administration (0.1 ml/kg). The contrast medium uptake rate at D-MRI and the signal intensity (SI) ratio on the FSE-IR sequence were measured. RESULTS: At baseline, mean contrast medium uptake rate was 136 ± 49.7% and the mean SI ratio was 5 ± 3. A high intra- and inter-observer agreement was found for the contrast medium uptake rate, whereas a low agreement was observed for the SI ratio. At 3 months' follow-up, reduction of the contrast medium uptake rate was observed in all patients with improved clinical findings (n = 34), whereas the SI ratio was reduced in 15/34 (44.1%) patients. Mean healing time was significantly related to the baseline contrast medium uptake rate (P=0.005); it was 5.3 ± 2.7 months in patients with contrast medium uptake rate ≤ 100%, compared with 9.1 ± 2.5 months in the remaining patients (P=0.0003). CONCLUSIONS: Contrast medium uptake rate obtained at D-MRI represents a reproducible parameter that is reliable for predicting and monitoring treatment outcome in acute Charcot foot.
PURPOSE: To evaluate the usefulness of magnetic resonance imaging (MRI) in assessing the level of activity of acute Charcot foot, monitoring treatment response and predicting healing time. MATERIALS AND METHODS: Forty diabeticpatients with acute Charcot foot were prospectively enrolled. Patients underwent limb immobilization and were followed every 3 months by clinical examination (skin temperature and circumferences) and MRI. MR protocol included T1-weighted and fast spin echo inversion recovery (FSE-IR) sequences, and a dynamic study (fast spoiled gradient echo), after gadolinium administration (0.1 ml/kg). The contrast medium uptake rate at D-MRI and the signal intensity (SI) ratio on the FSE-IR sequence were measured. RESULTS: At baseline, mean contrast medium uptake rate was 136 ± 49.7% and the mean SI ratio was 5 ± 3. A high intra- and inter-observer agreement was found for the contrast medium uptake rate, whereas a low agreement was observed for the SI ratio. At 3 months' follow-up, reduction of the contrast medium uptake rate was observed in all patients with improved clinical findings (n = 34), whereas the SI ratio was reduced in 15/34 (44.1%) patients. Mean healing time was significantly related to the baseline contrast medium uptake rate (P=0.005); it was 5.3 ± 2.7 months in patients with contrast medium uptake rate ≤ 100%, compared with 9.1 ± 2.5 months in the remaining patients (P=0.0003). CONCLUSIONS: Contrast medium uptake rate obtained at D-MRI represents a reproducible parameter that is reliable for predicting and monitoring treatment outcome in acute Charcot foot.
Authors: E B Jude; P L Selby; J Burgess; P Lilleystone; E B Mawer; S R Page; M Donohoe; A V Foster; M E Edmonds; A J Boulton Journal: Diabetologia Date: 2001-11 Impact factor: 10.122
Authors: Martin Libicher; C Kasperk; M Daniels-Wredenhagen; T Heye; H U Kauczor; P Nawroth; S Delorme; W Hosch Journal: Skeletal Radiol Date: 2012-05-16 Impact factor: 2.199
Authors: L Meacock; N L Petrova; Ana Donaldson; A Isaac; A Briody; R Ramnarine; M E Edmonds; D A Elias Journal: J Diabetes Res Date: 2017-11-05 Impact factor: 4.011
Authors: Alberto Bergamini; Francesca Bolacchi; Caterina Delfina Pesce; Giada Veneziano; Luigi Uccioli; Valentina Girardi; Laura De Corato; Maria Teresa Mondillo; Ettore Squillaci Journal: Int J Med Sci Date: 2016-10-20 Impact factor: 3.738
Authors: Tamara E Milne; Joseph R Rogers; Ewan M Kinnear; Helen V Martin; Peter A Lazzarini; Thomas R Quinton; Frances M Boyle Journal: J Foot Ankle Res Date: 2013-07-30 Impact factor: 2.303
Authors: Nina L Petrova; Nicholas K Donaldson; Maureen Bates; Wegin Tang; Timothy Jemmott; Victoria Morris; Tracy Dew; Lisa Meacock; David A Elias; Cajetan F Moniz; Michael E Edmonds Journal: Diabetes Care Date: 2021-06-04 Impact factor: 19.112